Curis (CRIS) Shareholder's Equity Growth (3y) (2013 - 2026)
Curis (CRIS) Shareholder's Equity Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-29.71% |
| Dec 31, 2025 |
-51.04% |
| Sep 30, 2025 |
-31.30% |
| Jun 30, 2025 |
-30.56% |
| Mar 31, 2025 |
-27.79% |
| Dec 31, 2024 |
-27.37% |
| Sep 30, 2024 |
-27.75% |
| Jun 30, 2024 |
-26.12% |
| Mar 31, 2024 |
-57.34% |
| Dec 31, 2023 |
-46.80% |
| Sep 30, 2023 |
44.77% |
| Jun 30, 2023 |
42.00% |
| Mar 31, 2023 |
42.75% |
| Dec 31, 2022 |
49.97% |
| Sep 30, 2022 |
60.60% |
| Jun 30, 2022 |
71.69% |
| Mar 31, 2022 |
96.04% |
| Dec 31, 2021 |
180.95% |
| Sep 30, 2021 |
408.65% |
| Jun 30, 2021 |
151.03% |
